Mapping of gene loci in the Q13-Q15 region of chromosome 12
- PMID:7606365
- DOI: 10.1007/BF00713052
Mapping of gene loci in the Q13-Q15 region of chromosome 12
Abstract
The gene loci CDK4, GLI, CHOP and MDM2 have been mapped to the q13-q15 region of chromosome 12. Using fluorescence in situ hybridization onto simultaneously DAPI-banded metaphase chromosomes and interphase nuclei, we have more precisely mapped and ordered these loci, together with a number of Genethon microsatellite markers. GLI and CHOP localize to 12q13.3-14.1, CDK4 to 12q14 and MDM2 to 12q14.3-q15, and the gene order is cen-GLI/CHOP-CDK4-MDM2. The Genethon microsatellites D12S80 and D12S83 flank MDM2.
Similar articles
- Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G.Simon R, et al.Oncogene. 2002 Apr 11;21(16):2476-83. doi: 10.1038/sj.onc.1205304.Oncogene. 2002.PMID:11971182
- Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP.Reifenberger G, et al.Cancer Res. 1996 Nov 15;56(22):5141-5.Cancer Res. 1996.PMID:8912848
- Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M, Bertoni F, Picci P, Benassi MS.Ragazzini P, et al.Histol Histopathol. 2004 Apr;19(2):401-11. doi: 10.14670/HH-19.401.Histol Histopathol. 2004.PMID:15024701
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.Sandberg AA.Sandberg AA.Cancer Genet Cytogenet. 2004 Nov;155(1):1-24. doi: 10.1016/j.cancergencyto.2004.08.005.Cancer Genet Cytogenet. 2004.PMID:15527898Review.No abstract available.
- Gli-type zinc finger proteins as bipotential transducers of Hedgehog signaling.Koebernick K, Pieler T.Koebernick K, et al.Differentiation. 2002 May;70(2-3):69-76. doi: 10.1046/j.1432-0436.2002.700201.x.Differentiation. 2002.PMID:12076333Review.
Cited by
- Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.Nielsen EM, Hansen L, Stissing T, Yanagisawa K, Borch-Johnsen K, Poulsen P, Vaag A, Hansen T, Pedersen O.Nielsen EM, et al.J Mol Med (Berl). 2005 May;83(5):353-61. doi: 10.1007/s00109-005-0647-3. Epub 2005 Apr 9.J Mol Med (Berl). 2005.PMID:15821902
- Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications.Lavernia J, Claramunt R, Romero I, López-Guerrero JA, Llombart-Bosch A, Machado I.Lavernia J, et al.Cancers (Basel). 2024 Jan 19;16(2):432. doi: 10.3390/cancers16020432.Cancers (Basel). 2024.PMID:38275873Free PMC article.Review.
- The Role ofp16 andMDM2 Gene Polymorphisms in Prolactinoma:MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.Turgut S, Ilhan M, Turan S, Karaman O, Yaylim I, Kucukhuseyin O, Tasan E.Turgut S, et al.In Vivo. 2017 May-Jun;31(3):357-363. doi: 10.21873/invivo.11067.In Vivo. 2017.PMID:28438863Free PMC article.
- Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization.Armengol G, Tarkkanen M, Virolainen M, Forus A, Valle J, Böhling T, Asko-Seljavaara S, Blomqvist C, Elomaa I, Karaharju E, Kivioja AH, Siimes MA, Tukiainen E, Caballín MR, Myklebost O, Knuutila S.Armengol G, et al.Br J Cancer. 1997;75(10):1403-9. doi: 10.1038/bjc.1997.242.Br J Cancer. 1997.PMID:9166930Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials